🇺🇸 FDA
Patent

US 9228001

Mutants of cholesterol-dependent cytolysins and uses thereof

granted A61KA61K38/00A61K39/00

Quick answer

US patent 9228001 (Mutants of cholesterol-dependent cytolysins and uses thereof) held by The Board of Regents of the University of Oklahoma expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61K39/00